[PHARMA] QoQ Annualized Quarter Result on 30-Sep-2020 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
19-Nov-2020
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2020
Quarter
30-Sep-2020 [#3]
Profit Trend
QoQ- -30.36%
YoY- 15.12%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Revenue 3,941,244 3,173,996 2,725,071 2,787,317 2,931,368 3,279,684 2,820,530 25.01%
PBT 107,536 126,096 35,793 65,732 90,412 123,520 -191,865 -
Tax -34,104 -34,784 -9,524 -21,310 -26,368 -33,860 42,418 -
NP 73,432 91,312 26,269 44,421 64,044 89,660 -149,447 -
-
NP to SH 73,680 92,544 27,489 45,093 64,756 89,596 -149,219 -
-
Tax Rate 31.71% 27.59% 26.61% 32.42% 29.16% 27.41% - -
Total Cost 3,867,812 3,082,684 2,698,802 2,742,896 2,867,324 3,190,024 2,969,977 19.27%
-
Net Worth 357,275 355,919 337,298 345,040 357,891 350,047 336,573 4.06%
Dividend
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Div 60,200 41,872 28,761 34,852 44,409 62,695 22,177 94.71%
Div Payout % 81.71% 45.25% 104.63% 77.29% 68.58% 69.98% 0.00% -
Equity
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Net Worth 357,275 355,919 337,298 345,040 357,891 350,047 336,573 4.06%
NOSH 261,991 261,705 261,705 261,705 261,705 261,229 261,229 0.19%
Ratio Analysis
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
NP Margin 1.86% 2.88% 0.96% 1.59% 2.18% 2.73% -5.30% -
ROE 20.62% 26.00% 8.15% 13.07% 18.09% 25.60% -44.33% -
Per Share
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
RPS 301.16 1,212.81 1,042.20 1,066.33 1,122.12 1,255.48 1,081.04 -57.37%
EPS 5.64 35.36 10.51 17.25 24.78 34.28 -57.19 -
DPS 4.60 16.00 11.00 13.33 17.00 24.00 8.50 -33.61%
NAPS 0.273 1.36 1.29 1.32 1.37 1.34 1.29 -64.52%
Adjusted Per Share Value based on latest NOSH - 261,705
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
RPS 273.46 220.23 189.08 193.40 203.39 227.56 195.70 25.01%
EPS 5.11 6.42 1.91 3.13 4.49 6.22 -10.35 -
DPS 4.18 2.91 2.00 2.42 3.08 4.35 1.54 94.70%
NAPS 0.2479 0.247 0.234 0.2394 0.2483 0.2429 0.2335 4.07%
Price Multiplier on Financial Quarter End Date
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Date 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 -
Price 5.29 3.26 5.00 4.32 2.22 1.26 2.06 -
P/RPS 1.76 0.27 0.48 0.41 0.20 0.10 0.19 341.66%
P/EPS 93.96 9.22 47.56 25.04 8.96 3.67 -3.60 -
EY 1.06 10.85 2.10 3.99 11.17 27.22 -27.76 -
DY 0.87 4.91 2.20 3.09 7.66 19.05 4.13 -64.63%
P/NAPS 19.38 2.40 3.88 3.27 1.62 0.94 1.60 428.22%
Price Multiplier on Announcement Date
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Date 20/08/21 21/05/21 17/03/21 19/11/20 19/08/20 19/05/20 20/02/20 -
Price 0.925 4.03 3.49 5.72 4.42 1.88 2.04 -
P/RPS 0.31 0.33 0.33 0.54 0.39 0.15 0.19 38.63%
P/EPS 16.43 11.40 33.20 33.16 17.83 5.48 -3.57 -
EY 6.09 8.77 3.01 3.02 5.61 18.24 -28.04 -
DY 4.97 3.97 3.15 2.33 3.85 12.77 4.17 12.42%
P/NAPS 3.39 2.96 2.71 4.33 3.23 1.40 1.58 66.42%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment